97 related articles for article (PubMed ID: 14567792)
21. Rho kinase inhibitors as potential therapeutic agents for cardiovascular diseases.
Hu E; Lee D
Curr Opin Investig Drugs; 2003 Sep; 4(9):1065-75. PubMed ID: 14582450
[TBL] [Abstract][Full Text] [Related]
22. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration.
Lepley D; Paik JH; Hla T; Ferrer F
Cancer Res; 2005 May; 65(9):3788-95. PubMed ID: 15867375
[TBL] [Abstract][Full Text] [Related]
23. An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors.
Chopra P; Nanda K; Chatterjee M; Bajpai M; Dastidar SG; Ray A
Anal Biochem; 2008 Sep; 380(1):143-5. PubMed ID: 18570885
[TBL] [Abstract][Full Text] [Related]
24. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
25. Localization of the gene coding for ROCK II/Rho kinase on human chromosome 2p24.
Takahashi N; Tuiki H; Saya H; Kaibuchi K
Genomics; 1999 Jan; 55(2):235-7. PubMed ID: 9933571
[TBL] [Abstract][Full Text] [Related]
26. High-affinity bisubstrate probe for fluorescence anisotropy binding/displacement assays with protein kinases PKA and ROCK.
Vaasa A; Viil I; Enkvist E; Viht K; Raidaru G; Lavogina D; Uri A
Anal Biochem; 2009 Feb; 385(1):85-93. PubMed ID: 19017524
[TBL] [Abstract][Full Text] [Related]
27. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
[TBL] [Abstract][Full Text] [Related]
28. A cell-based ultra-high-throughput screening assay for identifying inhibitors of D-amino acid oxidase.
Brandish PE; Chiu CS; Schneeweis J; Brandon NJ; Leech CL; Kornienko O; Scolnick EM; Strulovici B; Zheng W
J Biomol Screen; 2006 Aug; 11(5):481-7. PubMed ID: 16760370
[TBL] [Abstract][Full Text] [Related]
29. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
Meyer-ter-Vehn T; Sieprath S; Katzenberger B; Gebhardt S; Grehn F; Schlunck G
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4895-904. PubMed ID: 17065504
[TBL] [Abstract][Full Text] [Related]
30. Rho-associated protein kinase II (rock II) expression in normal and preeclamptic human placentas.
Ark M; Yilmaz N; Yazici G; Kubat H; Aktaş S
Placenta; 2005 Jan; 26(1):81-4. PubMed ID: 15664415
[TBL] [Abstract][Full Text] [Related]
31. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.
Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A
J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914
[TBL] [Abstract][Full Text] [Related]
32. A fluorescence lifetime based binding assay to characterize kinase inhibitors.
Lebakken CS; Hee Chol Kang ; Vogel KW
J Biomol Screen; 2007 Sep; 12(6):828-41. PubMed ID: 17644772
[TBL] [Abstract][Full Text] [Related]
33. Utilization of fluorescence polarization and time resolved fluorescence resonance energy transfer assay formats for SAR studies: Src kinase as a model system.
Newman M; Josiah S
J Biomol Screen; 2004 Sep; 9(6):525-32. PubMed ID: 15452339
[TBL] [Abstract][Full Text] [Related]
34. Adopting a practical statistical approach for evaluating assay agreement in drug discovery.
Sun D; Whitty A; Papadatos J; Newman M; Donnelly J; Bowes S; Josiah S
J Biomol Screen; 2005 Aug; 10(5):508-16. PubMed ID: 16093560
[TBL] [Abstract][Full Text] [Related]
35. A simple set-and-mix assay for screening of protein kinase inhibitors in cell lysates.
Asami Y; Oishi J; Kitazaki H; Kamimoto J; Kang JH; Niidome T; Mori T; Katayama Y
Anal Biochem; 2011 Nov; 418(1):44-9. PubMed ID: 21802396
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of fluorescence polarization and lifetime discriminated polarization for high throughput screening of serine/threonine kinases.
Fowler A; Swift D; Longman E; Acornley A; Hemsley P; Murray D; Unitt J; Dale I; Sullivan E; Coldwell M
Anal Biochem; 2002 Sep; 308(2):223-31. PubMed ID: 12419333
[TBL] [Abstract][Full Text] [Related]
37. Development of a Transcreener kinase assay for protein kinase A and demonstration of concordance of data with a filter-binding assay format.
Huss KL; Blonigen PE; Campbell RM
J Biomol Screen; 2007 Jun; 12(4):578-84. PubMed ID: 17409274
[TBL] [Abstract][Full Text] [Related]
38. Use of red-shifted dyes in a fluorescence polarization AKT kinase assay for detection of biological activity in natural product extracts.
Turek-Etienne TC; Lei M; Terracciano JS; Langsdorf EF; Bryant RW; Hart RF; Horan AC
J Biomol Screen; 2004 Feb; 9(1):52-61. PubMed ID: 15006149
[TBL] [Abstract][Full Text] [Related]
39. Establishment and application of a high throughput model for Rho kinase inhibitors screening based on fluorescence polarization.
Duan W; Sun L; Liu J; Wu X; Zhang L; Yan M
Biol Pharm Bull; 2006 Jun; 29(6):1138-42. PubMed ID: 16755006
[TBL] [Abstract][Full Text] [Related]
40. The application of fluorescence lifetime readouts in high-throughput screening.
Moger J; Gribbon P; Sewing A; Winlove CP
J Biomol Screen; 2006 Oct; 11(7):765-72. PubMed ID: 16943393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
